Back to Search
Start Over
Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis
- Source :
- The Pediatric infectious disease journal. 31(11)
- Publication Year :
- 2012
-
Abstract
- BACKGROUND: Drug resistance mutations compromise antiretroviral treatment (ART) effectiveness in HIV-1-infected children. Trends in drug resistance prevalence have not been previously evaluated in HIV-infected children in Spain. METHODS: HIV-1 variants, drug resistance prevalence dynamics and drug susceptibility were analyzed from 1993 to 2010 in HIV-infected children with available pol sequence, sample or drug resistance profile. HIV-1 variants were characterized by phylogenetic analysis. Resistance mutations in pretreated and naive patients were identified according to International AIDS Society-2010 and the World Health Organization list, respectively. RESULTS: In 232 patients, genotypic resistance profiles (n = 11) or pol sequences (n = 128) were recovered or newly generated from infected samples (n = 93). Patients were mainly in care at pediatric units (63%), were mostly Europeans (84%), with moderate AIDS symptoms (65%), on ART (91%) and infected by HIV-1 subtype B (89%). Transmitted major drug resistance mutations were selected in 6 (13.6%) of the 44 ART-naive children: 4.8%, 9.3% and 11.6%, for protease inhibitors, nucleoside reverse transcriptase inhibitors and nonnucleoside reverse transcriptase inhibitors, respectively. Overall resistance prevalence was higher (71.8%) among ART-exposed children: 39.9%, 66.5% and 35.3% for protease inhibitors, nucleoside reverse transcriptase inhibitors and nonnucleoside reverse transcriptase inhibitors, respectively. Resistance prevalence among ART-exposed children was higher in 2009 to 2010 relative to 1993 to 1999 for nonnucleoside reverse transcriptase inhibitors (42% versus 6%; P = 0.006), protease inhibitors (39% versus 13%; P = 0.004) and nucleoside reverse transcriptase inhibitors (63% versus 44%; P = NS). Susceptibility to each drug in resistant viruses was predicted. The rate of non-B infections increased in the last years, mainly caused by recombinant viruses. CONCLUSIONS: The increasing resistance prevalence among the HIV-infected pediatric population in Spain highlights the importance of specific drug resistance and drug susceptibility surveillance in long-term pretreated children to optimize treatment regimens.
- Subjects :
- Microbiology (medical)
Drug
Gene Expression Regulation, Viral
Male
Time Factors
Adolescent
Genotype
Anti-HIV Agents
media_common.quotation_subject
medicine.medical_treatment
HIV Infections
Drug resistance
Nucleoside Reverse Transcriptase Inhibitor
Young Adult
Acquired immunodeficiency syndrome (AIDS)
Antiretroviral Therapy, Highly Active
Drug Resistance, Viral
Prevalence
Medicine
Humans
Child
media_common
Protease
business.industry
Viral Load
medicine.disease
Virology
Reverse transcriptase
Infectious Diseases
Spain
pol Gene Products, Human Immunodeficiency Virus
Pediatrics, Perinatology and Child Health
Immunology
HIV-1
Female
business
Viral load
Subjects
Details
- ISSN :
- 15320987
- Volume :
- 31
- Issue :
- 11
- Database :
- OpenAIRE
- Journal :
- The Pediatric infectious disease journal
- Accession number :
- edsair.doi.dedup.....46d4628d9716aeac925b472faaa29fc9